Huron Consulting Group Inc. (HURN) SEC Filings & Earnings Calls
EquiReason read 11 Huron Consulting Group Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-07-28 — Huron reported Q2 2026 RBR of $465.6M (+15.7% YoY), adjusted EBITDA margin of 15.6%, and adjusted diluted EPS of $2.46 (+30.2% YoY)..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 3.1B
- P/E TTM
- 29.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
28 Jul 202610-QHuron reported Q2 2026 RBR of $465.6M (+15.7% YoY), adjusted EBITDA margin of 15.6%, and adjusted diluted EPS of $2.46 (+30.2% YoY).earningsopen
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses (RBR) · Q2-2026 | $466M | +16% y/y |
| Net income · Q2-2026 | $31M | +61% y/y |
| Adjusted EBITDA · Q2-2026 | $73M | +20% y/y |
| Adjusted diluted EPS · Q2-2026 | $2.46 | +30% y/y |
| Diluted EPS · Q2-2026 | $1.91 | +75% y/y |
| Revenue-generating professionals (total) · 2026-06-30 | 9,248 | +34% y/y |
| Consulting utilization rate · Consulting · Q2-2026 | 81.3% | |
| Digital utilization rate · Digital · Q2-2026 | 81.8% | |
| Healthcare segment operating margin · Healthcare · Q2-2026 | 30.1% | |
| Education segment operating margin · Education · Q2-2026 | 26.8% |
Risks flagged
Acquisition integration risk
“The increase includes $19.5 million of incremental RBR from our acquisitions completed since March 31, 2025.” · word for word
Interest expense increase
“Interest expense, net of interest income increased $2.7 million to $11.9 million in the second quarter of 2026 from $9.3 million in the second quarter of 2025, which was primarily attributable to higher levels of borrowing under our senior secured credit facility.” · word for word
28 Jul 20268-K · 2.02Revenues before reimbursable expenses (RBR) $466M (+16% y/y); Net income $31M (+61% y/y); Adjusted EBITDA $73M (+20% y/y); Guidance: Full-year RBR guidance raised to $1.85B-$1.89Bearningsopen
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses (RBR) · Q2-2026 | $466M | +16% y/y |
| Net income · Q2-2026 | $31M | +61% y/y |
| Adjusted EBITDA · Q2-2026 | $73M | +20% y/y |
| Diluted earnings per share · Q2-2026 | $1.91 | +75% y/y |
| Adjusted diluted earnings per share · Q2-2026 | $2.46 | +30% y/y |
| Net cash provided by operating activities · Q2-2026 | $121M | +51% y/y |
| Shares repurchased · Q2-2026 | 400,000 |
Guidance
Full-year RBR guidance raised to $1.85B-$1.89B
Raising full-year guidance on strong organic growth, margin expansion, and robust backlog.
Risks flagged
Acquisition integration risk (small tuck-ins)
“$19.5M incremental RBR from acquisitions completed since March 31, 2025.”
Dependence on AI capabilities for growth
“AI capabilities will continue to drive market-leading outcomes” · word for word
5 May 20268-K · 2.02Revenues before reimbursable expenses (RBR) $444M (+12% y/y); Net income $23M (-5% y/y); Adjusted EBITDA $51M (+22% y/y); Guidance: RBR $1.78B-$1.86Bearningsopen
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses (RBR) · Q1-2026 | $444M | +12% y/y |
| Net income · Q1-2026 | $23M | -5% y/y |
| Adjusted EBITDA · Q1-2026 | $51M | +22% y/y |
| Diluted earnings per share · Q1-2026 | $1.34 | +1% y/y |
| Adjusted diluted earnings per share · Q1-2026 | $1.73 | +3% y/y |
Guidance
RBR $1.78B-$1.86B
Full-year 2026 RBR guidance reaffirmed; strong Q1 performance supports outlook; margin expansion trajectory continues.
Risks flagged
Tax expense volatility impacted net income; Q1 2026 had $3.8M tax expense vs $3.1M tax benefit in Q1 2025.
“Net income for the first quarter of 2026 includes $3.8 million of income tax expense, compared to an income tax benefit of $3.1 million recorded in the first quarter of 2025.” · word for word
5 May 202610-QRevenues before reimbursable expenses (RBR) $444M (+12% y/y); Net income $23M (-5% y/y); Adjusted EBITDA $51M (+22% y/y)open
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses (RBR) · Q1-2026 | $444M | +12% y/y |
| Net income · Q1-2026 | $23M | -5% y/y |
| Adjusted EBITDA · Q1-2026 | $51M | +22% y/y |
| Adjusted diluted EPS · Q1-2026 | $1.73 | +3% y/y |
| Operating cash flow · Q1-2026 | $-162M | |
| Healthcare RBR · Healthcare · Q1-2026 | $225M | +14% y/y |
| Education RBR · Education · Q1-2026 | $127M | +4% y/y |
| Commercial RBR · Commercial · Q1-2026 | $91M | +22% y/y |
Risks flagged
Leverage Increase
“Our Consolidated Leverage Ratio as of March 31, 2026 was 3.14 to 1.00, compared to 1.93 to 1.00 as of December 31, 2025.” · word for word
Digital Capability Slowdown
“RBR within our Digital capability increased $0.3 million, or 0.2%, in the first quarter of 2026 to $172.1 million, compared to $171.8 million in the first quarter of 2025; and reflected an increase in RBR in our Education segment, partially offset by a decrease in RBR in our Commercial and Healthcare segments.” · word for word
Tax Rate Volatility
“For the three months ended March 31, 2026, our effective tax rate was 14.1% as we recognized income tax expense of $3.8 million on income of $27.1 million.” · word for word
20 Mar 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance, and 2025 performance.open
Figures in the filing · each found in the filing text
| Adjusted EBITDA Margin · FY2025 | 14.3% | |
| Adjusted Diluted EPS · FY2025 | $7.83 | +21% y/y |
| Net Income · FY2025 | $105M | -10% y/y |
| Free Cash Flow · FY2025 | $162M | -4% y/y |
| Total Shareholder Return (TSR) · FY2025 | 39.0% | |
| Employees · 2025-12-31 | 8,600 |
Guidance
Low double-digit annual RBR growth; expand adjusted EBITDA margin to 15-17% by 2029; convert 75% of adjusted EBITDA to free cash flow; double adjusted diluted EPS by 2029
Medium-term financial targets reaffirmed from 2025 Investor Day, with strong 2025 performance as proof of execution.
Risks flagged
Talent retention and competition
“Huron operates in a highly competitive talent market and our compensation philosophy is designed to pay-for-performance, rewarding and retaining our highest performing employees” · word for word
Equity dilution from compensation
“We recognize the dilutive impact of granting equity awards, and we reflect the expense associated with these awards in our adjusted EBITDA and adjusted diluted earnings per share metrics.” · word for word
24 Feb 20268-K · 2.02Revenues before reimbursable expenses (RBR) $432M (+11% y/y); Net income $31M (-10% y/y); Adjusted EBITDA $68M (+20% y/y); Guidance: 2026 revenue guidance $1.78B-$1.86B; ~10% growth at midpointearningsopen
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses (RBR) · Q4-2025 | $432M | +11% y/y |
| Net income · Q4-2025 | $31M | -10% y/y |
| Adjusted EBITDA · Q4-2025 | $68M | +20% y/y |
| Diluted EPS · Q4-2025 | $1.72 | -7% y/y |
| Adjusted diluted EPS · Q4-2025 | $2.17 | +14% y/y |
| Revenues before reimbursable expenses (FY) · FY2025 | $1.66B | +12% y/y |
| Net income (FY) · FY2025 | $105M | -10% y/y |
| Adjusted EBITDA (FY) · FY2025 | $238M | +18% y/y |
| Diluted EPS (FY) · FY2025 | $5.84 | -7% y/y |
| Adjusted diluted EPS (FY) · FY2025 | $7.83 | +21% y/y |
Guidance
2026 revenue guidance $1.78B-$1.86B; ~10% growth at midpoint
2026 guidance implies continued double-digit revenue growth with margin expansion, supported by strong Q4 beat and AI-driven opportunities.
Risks flagged
Acquisition integration risk
“$27.3M incremental RBR from acquisitions in Q4; integration execution key.”
Digital capability decline in Healthcare segment
“Decreases in demand for Digital capability within Healthcare segment partially offset growth.”
24 Feb 202610-KNumber of employees 8,610; Number of clients served 2,000; Top 10 client concentration 19open
Figures in the filing · each found in the filing text
| Number of employees · FY2025 | 8,610 | |
| Number of clients served · FY2025 | 2,000 | |
| Top 10 client concentration · FY2025 | 19.0% | |
| Employee engagement score · FY2025 | $83.00 | |
| Coach quality score · FY2025 | $83.00 | |
| Volunteer hours · FY2025 | 16,600 | |
| Number of managing directors and principals · FY2025 | 305 | |
| Goodwill - Healthcare · Healthcare · FY2025 | $512M | |
| Goodwill - Education · Education · FY2025 | $151M | |
| Goodwill - Commercial · Commercial · FY2025 | $124M |
Risks flagged
Talent retention and competition risk
“If we are unable to hire and retain talented people in an industry where there is great competition for talent, it could have a serious negative effect on our prospects and results of operations.” · word for word
Client concentration and short-term contracts risk
“Many of our client contracts are short-term in duration and may be terminated by our clients with little or no notice and without penalty, which may cause our operating results to be unpredictable and may result in unexpected declines in our utilization and revenues.” · word for word
Healthcare and education regulatory risk
“The healthcare and education industries are highly regulated and are subject to changing political, legislative, regulatory, and other influences. Uncertainty in any of these areas could cause our clients to delay or postpone decisions to use our services.” · word for word
India operations risk
“We have significant operations in India, including approximately 3,500 employees, which could subject the Company to country-specific risks or exacerbate certain other risks.” · word for word
28 Oct 20258-K · 2.02Revenues before reimbursable expenses $432M (+17% y/y); net income $30M (+12% y/y); adjusted EBITDA $67M (+23% y/y); Guidance: Adjusted diluted EPS guidance raised to $7.60 midpoint; RBR guidance affirmed at $1.65B-$1.67Bearningsopen
Figures in the filing · each found in the filing text
| revenues before reimbursable expenses · Q3-2025 | $432M | +17% y/y |
| net income · Q3-2025 | $30M | +12% y/y |
| adjusted EBITDA · Q3-2025 | $67M | +23% y/y |
| diluted earnings per share · Q3-2025 | $1.71 | +16% y/y |
| adjusted diluted earnings per share · Q3-2025 | $2.10 | +25% y/y |
| full year 2025 adjusted diluted EPS guidance midpoint · FY2025 | $7.60 |
Guidance
Adjusted diluted EPS guidance raised to $7.60 midpoint; RBR guidance affirmed at $1.65B-$1.67B
Raised adjusted diluted EPS guidance, affirmed RBR guidance, strong demand across segments.
Risks flagged
Non-cash impairment charge on convertible debt investment impacted net income.
“$8.2 million non-cash impairment charge, net of tax, related to convertible debt investment in a third-party.” · word for word
Integration of acquisitions may pose execution risk.
“Incremental revenues from acquisitions of $28.3 million; amortization of intangible assets increased.”
28 Oct 202510-QHuron reported strong Q3 2025 results with revenue up 16.8%, adjusted EBITDA margin expansion, and adjusted diluted EPS growth of 25%, driven by broad-based demand across segments.earningsopen
Figures in the filing · each found in the filing text
| Revenues before reimbursable expenses · Q3-2025 | $432M | +17% y/y |
| Net income · Q3-2025 | $30M | +12% y/y |
| Adjusted EBITDA · Q3-2025 | $67M | +23% y/y |
| Diluted earnings per share · Q3-2025 | $1.71 | +16% y/y |
| Adjusted diluted earnings per share · Q3-2025 | $2.10 | +25% y/y |
| Healthcare segment operating income margin · Healthcare · Q3-2025 | 30.9% | |
| Education segment operating income margin · Education · Q3-2025 | 25.7% | |
| Commercial segment operating income margin · Commercial · Q3-2025 | 16.4% |
Risks flagged
Commercial segment margin compression
“Commercial operating margin decreased to 16.4% from 24.5% primarily due to the increases in salaries and related expenses for our revenue-generating professionals and contractor expenses, as percentages of revenues before reimbursable expenses.” · word for word
Interest expense increase
“Interest expense, net of interest income increased $4.2 million to $11.0 million in the third quarter of 2025 from $6.8 million in the third quarter of 2024, which was primarily attributable to higher levels of borrowing and higher interest rates under our senior secured credit facility during the third quarter of 2025 compared to the third quarter of 2024.” · word for word
Acquisition integration risk
“Transaction-related expenses: $2,354 thousand for Q3 2025 vs $716 thousand for Q3 2024.”
Government contract awards
federal awards · contract value, often multi-year| Date | Agency | Value | What for |
|---|---|---|---|
| 2026-09-29 | Department of Veterans Affairs | $27M | REVENUE OPERATIONS WORKFLOW, PAYER COMPLIANCE, AND TECHNICAL PROCESS OPTIMIZATION (ROWT) |
Huron Consulting Group Inc. — questions
- What did Huron Consulting Group Inc. file recently?
- 11 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-28 — Huron reported Q2 2026 RBR of $465.6M (+15.7% YoY), adjusted EBITDA margin of 15.6%, and adjusted diluted EPS of $2.46 (+30.2% YoY).
Every figure on this page comes from Huron Consulting Group Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.